scispace - formally typeset
S

Seyed Javad Mowla

Researcher at Tarbiat Modares University

Publications -  244
Citations -  6288

Seyed Javad Mowla is an academic researcher from Tarbiat Modares University. The author has contributed to research in topics: microRNA & Gene. The author has an hindex of 34, co-authored 221 publications receiving 5237 citations. Previous affiliations of Seyed Javad Mowla include Salk Institute for Biological Studies.

Papers
More filters
Journal ArticleDOI

Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor

TL;DR: The biosynthesis and post-translational processing of the brain-derived neurotrophic factor precursor (pro-BDNF) in cells infected with a pro-BD NF-encoding vaccinia virus is examined to suggest that 28-kDa pro- BDNF is not an obligatory intermediate in the formation of the 14-k da form in the constitutive secretory pathway.
Journal ArticleDOI

Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization

TL;DR: In vitro studies suggest that SKI-1 is a Ca2+-dependent serine proteinase exhibiting a wide pH optimum for cleavage of pro-brain-derived neurotrophic factor and phylogenetically ancestral human, rat, and mouse type I membrane-bound proteinase called subtilisin/kexin-isozyme-1 (SKI- 1).
Journal ArticleDOI

OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.

TL;DR: A distinctive expression pattern for OCT4 spliced variants in different cell types is demonstrated and the necessity of defining the type of OCT4 when addressing the expression of this gene in different human cells is highlighted.
Journal ArticleDOI

OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer

TL;DR: This study demonstrated, for the first time, the expression of OCT‐4 in bladder cancer and a further clue to the involvement of embryonic genes in carcinogenesis.
Journal ArticleDOI

MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.

TL;DR: The findings suggest that exosomal transfer of miR-100 may be a novel mechanism underlying the paracrine effects of MSC-derived exosomes and may provide a means by which these vesicles can modulate vascular responses within the microenvironment of breast cancer cells.